Quick Answer
XBiotech Inc. reported Gross Profit of $0.00 for the year ending 2023.
- XBiotech Inc. showed a decrease of -100.0% in Gross Profit from 2022 to 2023.
- This data is from XBiotech Inc.'s annual report (Form 10-K), filed with the SEC on March 15, 2024.
- XBRL data for this metric is available from 2018 to 2023 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2019: $0.00 | Q3 2019: $0.00 | Q1 2020: $3.01 million | Q2 2020: $2.30 million | Q3 2020: $1.12 million | Q1 2021: $2.55 million | Q2 2021: $3.17 million | Q3 2021: $3.41 million | Q1 2022: $287.0 thousand | Q2 2022: $1.32 million | Q3 2022: $1.47 million | Q1 2023: $0.00 | Q2 2023: $0.00 | Q3 2023: $0.00.
- Historical annual values: Fiscal year 2023: $0.00 | Fiscal year 2022: $3.36 million | Fiscal year 2021: $12.57 million | Fiscal year 2020: $9.45 million | Fiscal year 2019: $0.00 | Fiscal year 2018: $0.00.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: